MGLN - Magellan Health, Inc.
| Previous Close | 66.04 |
| Open | 66.55 |
| Bid | 66.88 x 900 |
| Ask | 66.91 x 800 |
| Day's Range | 65.75 - 67.57 |
| 52 Week Range | 51.88 - 99.90 |
| Volume | 194,632 |
| Avg. Volume | 254,185 |
| Market Cap | 1.608B |
| Beta (3Y Monthly) | 0.68 |
| PE Ratio (TTM) | 124.74 |
| EPS (TTM) | 0.54 |
| Earnings Date | Jul 25, 2019 - Jul 29, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 76.75 |
-
Markit • 17 hours ago
See what the IHS Markit Score report has to say about Magellan Health Inc.
Magellan Health Inc NASDAQ/NGS:MGLNView full report here! Summary * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for MGLN with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold MGLN had net inflows of $1.02 billion over the last one-month. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
-
Business Wire • 19 hours ago
Magellan Rx Management Pioneers Novel Drug Wastage Program, Savings Exceed $46 Million in First Year, While Promoting High Quality Care for Members
Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (MGLN), has launched an innovative solution to control spend for high-cost infusible drugs, while promoting high quality care for members. Payers are often faced with challenges like limited vial size options and availability that can lead to excessive spend in categories such as oncology and autoimmune conditions. The Magellan Rx drug wastage program leverages prior authorization and dosing protocols, in collaboration with providers, to identify clinically-appropriate opportunities to reduce waste.
-
Insider Monkey • 5 days ago
Hedge Funds Have Never Been More Bullish On Magellan Health Inc (MGLN)
Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by nearly 9 percentage points since the end of the third quarter of 2018 as investors worried over the possible ramifications of rising interest rates and escalation of the trade war with China. The hedge funds and institutional investors we track typically invest more […]
-
Zacks • 12 days ago
MGLN vs MOH: Which Health Insurance Stock is Placed Better?
Molina Healthcare (MOH) and Magellan Health (MGLN) are poised to grow in the expanding health insurance industry. Here we try to figure out which stock is positioned better.
-
Zacks • 13 days ago
U.S. Service Sector Expands at a Brisk Pace: Top 5 Winners
The U.S. service sector grows faster in May defying slowdown in economic growth and rising trade tensions.
-
Business Wire • 15 days ago
Magellan Rx Management Launches Oncology Biosimilar Medical Pharmacy Solution, Aims to Improve Member Access, Reduce Costs and Save Customers Millions in Drug Spend
Magellan Rx Management, the pharmacy benefit management division of Magellan Health, Inc. , today announced the launch of a medical pharmacy solution targeting oncology therapeutic biosimilars.
-
Zacks • 18 days ago
Why Is Magellan Health (MGLN) Down 2.4% Since Last Earnings Report?
Magellan Health (MGLN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
-
Business Wire • 18 days ago
Magellan Health Opens a Toll-Free Crisis Line to Provide Free Counseling and Referral Services to Residents Impacted by the Shooting at the Virginia Beach Municipal Center
Magellan will provide free, confidential counseling services and other resources, such as tip sheets about trauma and how to process it, resiliency after such situations, and how to talk about these situations with children who may be following the news in the media.
-
-
Zacks • 20 days ago
4 Stocks to Buy Despite Year-to-Date Fall in Health Insurance
Despite regulatory noise, strong fundamentals and changing demographics of the country poise health insurance stocks for growth.
-
Business Wire • 27 days ago
Magellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals Impacted by Severe Weather in Missouri
Counseling and resources available free-of-charge to local community
-
Simply Wall St. • 28 days ago
Is Magellan Health, Inc.'s (NASDAQ:MGLN) CEO Pay Justified?
Barry Smith became the CEO of Magellan Health, Inc. (NASDAQ:MGLN) in 2013. This analysis aims first to contrast CEO...
-
Business Wire • last month
Magellan Rx Management’s Second Annual Employer Market Insights Report Highlights Market Dynamics and Opportunities for Traditional and Specialty Drugs
Unique report provides current and forward-looking pharmacy trends and cost management strategies for 2020 and beyond
-
Insider Monkey • last month
Engaged Capital’s Latest Moves
Engaged Capital is a hedge fund that was founded in 2012 by Glenn W. Wellin, who previously sharpened his investment skills at famous Relational Investors where he was a Principal and Managing Director. The fund was launched with an initial capital of $85 million, and it has grown big since – holding $796.16 million in […]
-
Thomson Reuters StreetEvents • last month
Edited Transcript of MGLN earnings conference call or presentation 2-May-19 11:30am GMT
Q1 2019 Magellan Health Inc Earnings Call
-
American City Business Journals • 2 months ago
Magellan Health falls far short of analysts' Q1 estimates
The company is gearing up for its pivotal annual shareholders' meeting in June at which four nominees put forth from an activist investor hedge fund are looking to join the board.
-
Motley Fool • 2 months agoMagellan Health Inc (MGLN) Q1 2019 Earnings Call Transcript
MGLN earnings call for the period ending March 31, 2019.
-
Zacks • 2 months ago
Magellan Health (MGLN) Misses Q1 Earnings Estimates
Magellan Health (MGLN) delivered earnings and revenue surprises of -27.27% and 0.05%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
-
Associated Press • 2 months ago
Magellan Health: 1Q Earnings Snapshot
On a per-share basis, the Scottsdale, Arizona-based company said it had profit of 2 cents. Earnings, adjusted for one-time gains and costs, were 40 cents per share. The results fell short of Wall Street ...
